Universal Biosensors, Inc. (ASX:UBI)
Australia
· Delayed Price · Currency is AUD 0.0580
+0.0030 (5.45%)
Apr 30, 2025, 4:10 PM AEST
Universal Biosensors Cash Flow Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -14.24 | -6.74 | -26.85 | -10.51 | -7.64 | Upgrade
|
| Depreciation & Amortization | 0.8 | 0.97 | 2.79 | 2.57 | 2.43 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 0 | -0 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 11.01 | - | - | Upgrade
|
| Stock-Based Compensation | 0.1 | 0.2 | 0.32 | 0.09 | 0.17 | Upgrade
|
| Other Operating Activities | -0.59 | 0.09 | 0.32 | -0.59 | 0.37 | Upgrade
|
| Change in Accounts Receivable | 1.17 | -1.18 | -0.47 | -0.41 | 0.04 | Upgrade
|
| Change in Inventory | -1.21 | -1.24 | -1 | -0.26 | -0.8 | Upgrade
|
| Change in Accounts Payable | -0.94 | -1.39 | 0.2 | 1.75 | -0.07 | Upgrade
|
| Change in Unearned Revenue | -0.04 | 0.03 | -0.03 | -1.4 | -2.48 | Upgrade
|
| Change in Other Net Operating Assets | 2.63 | -5.37 | -0.98 | -1.14 | -0.32 | Upgrade
|
| Operating Cash Flow | -12.3 | -14.62 | -14.7 | -9.9 | -8.29 | Upgrade
|
| Capital Expenditures | -0.41 | -1.47 | -1.57 | -0.66 | -0.39 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 0 | Upgrade
|
| Other Investing Activities | - | - | - | - | 0.01 | Upgrade
|
| Investing Cash Flow | -0.41 | -1.47 | -1.57 | -0.66 | -0.37 | Upgrade
|
| Short-Term Debt Issued | - | 1.06 | 1 | 0.02 | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 0.04 | Upgrade
|
| Total Debt Issued | - | 1.06 | 1 | 0.02 | 0.04 | Upgrade
|
| Short-Term Debt Repaid | -0.91 | -1.1 | -1 | - | - | Upgrade
|
| Total Debt Repaid | -0.91 | -1.1 | -1 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -0.91 | -0.04 | - | 0.02 | 0.04 | Upgrade
|
| Issuance of Common Stock | 12.02 | - | 24.97 | 0.08 | - | Upgrade
|
| Other Financing Activities | -0.01 | -0.04 | 0.04 | - | - | Upgrade
|
| Financing Cash Flow | 11.1 | -0.08 | 25.01 | 0.1 | 0.04 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.08 | -0.05 | -0.02 | 0.51 | -0.52 | Upgrade
|
| Net Cash Flow | -1.7 | -16.23 | 8.73 | -9.96 | -9.14 | Upgrade
|
| Free Cash Flow | -12.71 | -16.09 | -16.27 | -10.56 | -8.68 | Upgrade
|
| Free Cash Flow Margin | -202.35% | -242.62% | -359.50% | -182.79% | -270.97% | Upgrade
|
| Free Cash Flow Per Share | -0.05 | -0.08 | -0.08 | -0.06 | -0.05 | Upgrade
|
| Levered Free Cash Flow | -9.44 | -19.86 | -11.14 | -8.7 | -8.35 | Upgrade
|
| Unlevered Free Cash Flow | -9.43 | -19.85 | -11.13 | -8.7 | -8.35 | Upgrade
|
| Change in Net Working Capital | -0.68 | 9.12 | -2.26 | 1.3 | 2.71 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.